Leading diagnostic chain Dr Lal PathLabs is all set to launch its initial public offering (IPO) soon. The company has already received Securities and Exchange Board of India’s (SEBI) approval for the same.
The company had filed its Draft Red Herring Prospectus (DRHP) with SEBI in September for the IPO wherein the promoters and other existing shareholders will collectively sell 1.16 crore shares of the company. The main promoter group plans to divest five percent, while other investors such as Wagner and Westbridge Crossover Fund will divest 9.1 percent stake.
Dr Lal PathLabs is a pioneer diagnostic centre in India that provides blood test services. It is believed to be the most trusted pathology lab in the country.
| Company Name | CMP |
|---|---|
| Apollo Hospital Ent. | 8495.95 |
| Max Healthcare Inst | 1008.95 |
| Narayana Hrudayalay | 1861.80 |
| Aster DM Healthcare | 814.20 |
| Global Health | 1228.60 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: